Novartis | NOVN - Eps Utile Per Azione


Fiscal Calendario Efettivo Consenso Precedente Data
FY2026Q1 Mar/2026 1.99 2.28 Apr/28
FY2025Q4 Dec/2025 2.03 1.98 Apr/02
FY2025Q3 Sep/2025 2.04 1.58 Oct/28
FY2025Q2 Jun/2025 2.42 1.97 Jul/17
FY2025Q1 Mar/2025 2.28 1.80 Apr/29




Eps Cambiamento Data
AbbVie USD 2.65 0.06 2026-03
Alcon AG USD 0.85 0.07 2026-03
Almirall EUR 0.07 0.03 2025-12
Amgen USD 5.15 0.14 2026-03
AstraZeneca USD 2.58 0.46 2026-03
Autolus Therapeutics Ltd USD -0.27 0.07 2026-03
Bayer EUR 2.71 2.09 2026-03
Biogen USD 3.57 1.58 2026-03
Bristol-Myers Squibb USD 1.58 0.32 2026-03
Eli Lilly USD 8.55 1.01 2026-03
Fresenius EUR 0.82 0.04 2026-03
Fresenius Medical Care EUR 0.91 0.53 2026-03
Genmab DKK 3.69 2.77 2025-12
Gilead Sciences USD 2.03 0.17 2026-03
GlaxoSmithKline GBP 0.43 0.17 2026-03
GRIFOLS EUR 0.14 0.11 2026-03
Hikma Pharmaceutical USD 0.65 0.12 2025-12
J&J USD 2.7 0.24 2026-03
Lakefront Biotherapeutics EUR -0.84 12.73 2026-03
Lonza CHF 6.07 1.92 2025-06
Merck EUR 2.11 0.23 2026-03
Merck USD -1.28 3.32 2026-03
Novartis USD 1.99 0.04 2026-03
Novartis USD 1.99 0.45 2026-03
Novo Nordisk DKK 10.91 4.87 2026-03
Orion EUR 0.66 1.19 2026-03
Pfizer USD 0.75 0.09 2026-03
Philips EUR 0.23 0.37 2026-03
Recordati EUR 0.73 0 2026-03
Regeneron Pharmaceuticals USD 9.47 1.97 2026-03
Roche Holding CHF 8.37 2.95 2025-12
Sanofi EUR 1.88 0.35 2026-03
UCB EUR 5.65 3.21 2025-12